# Problem Definition Validation

## Purpose

Before committing to a project idea, we must verify that the problem is real, relevant to the competition, and aligned with Medical IT career goals.

The goal is to avoid a plausible-sounding but unsupported problem statement.

## Validation Questions

### 1. Is The Problem Real?

We need evidence that the workflow problem exists in clinical research, drug development, hospital data management, or regulatory documentation.

Acceptable evidence:

- official guidelines,
- peer-reviewed papers,
- public clinical research standards,
- government or regulatory documents,
- public trial registry requirements,
- well-documented industry reports, with caution.

### 2. Is It Relevant To Drug Development?

The problem must connect to at least one drug development process:

- clinical trial protocol design,
- trial feasibility,
- patient eligibility/recruitment,
- safety monitoring,
- endpoint/data collection planning,
- regulatory or ethics documentation,
- evidence review for trial planning.

### 3. Is It Relevant To Medical IT?

The problem should connect to:

- hospital information systems,
- EMR/EHR data fields,
- clinical research data capture,
- audit trails,
- data quality,
- workflow integration,
- privacy and governance boundaries.

### 4. Is Agentic AI Actually Useful?

Agentic AI should be justified only if the workflow requires:

- multi-step planning,
- searching multiple sources,
- comparing evidence,
- checking protocol sections,
- using tools or databases,
- identifying missing or inconsistent items,
- generating traceable review output.

If a simple checklist is enough, the agent design is overkill.

### 5. Can We Evaluate It?

The problem is safer if outputs can be evaluated with:

- predefined checklist coverage,
- missing-item detection,
- citation relevance,
- consistency checks,
- human review rubric,
- scenario-based test cases.

### 6. What Should The Agent Not Do?

The agent must not be framed as:

- a clinical decision-maker,
- a regulatory authority,
- a diagnostic or treatment recommender,
- a replacement for IRB, CRA, CRC, PI, or regulatory experts,
- a system that uses real patient data without governance.

## Evidence Labels

Use these labels in research notes:

- `Source-backed`: directly supported by a cited source.
- `Reasonable inference`: inferred from multiple sources, but not directly stated.
- `Assumption`: plausible but still needs validation.
- `Do not claim`: too weak or risky to include.

## Current Hypothesis To Validate

Clinical trial protocol planning and review is a real drug-development workflow where missing or inconsistent protocol elements, evidence gaps, and data collection feasibility issues can create downstream burden.

Our Medical IT-specific hypothesis:

> A protocol review agent can help early-stage teams identify missing protocol components, evidence gaps, and hospital data-readiness risks before full expert review.

This must be validated before we expand the proposal.
